We are live on ! Find out more
IART icon

Integra LifeSciences
IART

264 hedge funds and large institutions have $5.09B invested in Integra LifeSciences in 2021 Q2 according to their latest regulatory filings, with 38 funds opening new positions, 95 increasing their positions, 77 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 29

23% more repeat investments, than reductions

Existing positions increased: 95 | Existing positions reduced: 77

3% more funds holding

Funds holding: 257 → 264 (+7)

0.95% more ownership

Funds ownership: 87.5% → 88.46% (+0.95%)

0% more capital invested

Capital invested by funds: $5.09B → $5.09B (+$4.06M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
264
Holders Change
+7
Holders Change %
+2.72%
% of All Funds
4.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
38
Increased
95
Reduced
77
Closed
29
Calls
$1.71M
Puts
–
Net Calls
+$1.71M
Net Calls Change
+$1.23M

Top Buyers

1
EVM
Eaton Vance Management
Massachusetts
+$14.8M
2
First Trust Advisors
First Trust Advisors
Illinois
+$12.5M
3
Arrowstreet Capital
Arrowstreet Capital
Massachusetts
+$11.9M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$11.6M
5
Macquarie Group
Macquarie Group
Australia
+$11.4M

Top Sellers

1
Invesco
Invesco
Georgia
-$17.9M
2
Millennium Management
Millennium Management
New York
-$14.3M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.63M
4
MPAM
Monarch Partners Asset Management
Massachusetts
-$5.71M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$5.49M
Name Holding Trade Value Shares
Change 		Change in
Stake
P
151
Pitcairn
Pennsylvania
$631K -$19.1K -270 -3%
BAM
152
Blueshift Asset Management
New Jersey
$601K +$623K +8,803 New
ECM
153
ExodusPoint Capital Management
New York
$581K +$602K +8,513 New
X
154
Xponance
Pennsylvania
$568K +$61.9K +875 +12%
ProShare Advisors
155
ProShare Advisors
Maryland
$541K +$81.3K +1,149 +17%
US Bancorp
156
US Bancorp
Minnesota
$536K -$147K -2,084 -21%
Verition Fund Management
157
Verition Fund Management
Connecticut
$523K +$542K +7,658 New
Pacer Advisors
158
Pacer Advisors
Pennsylvania
$510K -$6.36K -90 -1%
LWM
159
Loveless Wealth Management
Montana
$496K – – –
Osaic Holdings
160
Osaic Holdings
Arizona
$493K -$495 -7 -0.1%
IMRF
161
Illinois Municipal Retirement Fund
Illinois
$492K – – –
Zurich Cantonal Bank
162
Zurich Cantonal Bank
Switzerland
$476K -$36.3K -513 -7%
BC
163
Bridgefront Capital
Texas
$456K +$473K +6,684 New
SAM
164
Securian Asset Management
Minnesota
$444K -$7.07K -100 -2%
CGH
165
Crossmark Global Holdings
Texas
$444K +$23.3K +330 +5%
ZB
166
Zions Bancorporation
Utah
$443K +$64.1K +906 +16%
Deutsche Bank
167
Deutsche Bank
Germany
$419K -$170K -2,399 -28%
TRCT
168
Tower Research Capital (TRC)
New York
$396K +$152K +2,145 +59%
Janney Montgomery Scott
169
Janney Montgomery Scott
Pennsylvania
$382K – – –
GAM
170
Gotham Asset Management
New York
$381K +$395K +5,585 New
MSRPS
171
Maryland State Retirement & Pension System
Maryland
$378K – – –
VIM
172
Vista Investment Management
Pennsylvania
$375K – – –
JMPWA
173
JP Morgan Private Wealth Advisors
California
$372K +$37.5K +531 +11%
BAM
174
Burgundy Asset Management
Ontario, Canada
$355K – – –
CCP
175
Corient Capital Partners
California
$351K +$1.41K +20 +0.4%
5 6
7
8 9

IART Hedge Fund Activity: Q2 2021 in Review

264 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q2 2021, worth a combined $5.09B — up 0.08% from $5.09B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new IART positions and 29 closed out — a net gain of 9 holders — while 95 added to existing stakes and 77 trimmed.

The largest buyer was Eaton Vance Management, adding an estimated $14.8M. The largest seller was Invesco, cutting an estimated $17.9M.

  • 264 institutional investors held Integra LifeSciences (IART) as of Q2 2021, up from 257 in Q1 2021.
  • Funds reported $5.09B of Integra LifeSciences stock for Q2 2021, up 0.08% quarter-over-quarter.
  • 38 funds opened new Integra LifeSciences positions in Q2 2021 and 29 closed out, a net change of +9 holders.
  • The largest Integra LifeSciences buyer in Q2 2021 was Eaton Vance Management, an estimated $14.8M added.
  • The largest Integra LifeSciences seller in Q2 2021 was Invesco, an estimated $17.9M sold.

Based on aggregated 13F filings for Q2 2021.